External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma: A prospective, randomized study - Quality-of-life analysis

International Journal of Gynecological Cancer

Volumn 22, Issue 7, 2012, Pages 1281-1288

  Sorbe, Bengt Göran ^a   Horvath, György ^b   Andersson, Håkan ^b   Boman, Karin ^c   Lundgren, Caroline ^d   Pettersson, Birgitta ^e  

^a ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e MEDICAL PRODUCTS AGENCY   (Sweden)

Author keywords

Endometrial cancer; Medium risk group; Postoperative radiotherapy; Quality of life

Indexed keywords

ABDOMINAL HYSTERECTOMY; ADULT; AGED; BLADDER DISEASE; BRACHYTHERAPY; CANCER CONTROL; CANCER RECURRENCE; CONFERENCE PAPER; CONTROLLED STUDY; DECREASED APPETITE; DIARRHEA; DISTANT METASTASIS; ENDOMETRIUM CARCINOMA; ENTEROPATHY; EXTERNAL BEAM RADIOTHERAPY; FATIGUE; FEMALE; FOLLOW UP; HUMAN; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; NAUSEA AND VOMITING; OVERALL SURVIVAL; PARTIAL BODY RADIATION; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RADIATION DOSE; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL; RECURRENT CANCER; SALPINGOOOPHORECTOMY; VAGINAL BRACHYTHERAPY; ARTICLE; CANCER GRADING; CANCER STAGING; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; ENDOMETRIUM TUMOR; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PELVIS TUMOR; POSTOPERATIVE PERIOD; PROGNOSIS; RISK FACTOR; SURVIVAL RATE; TUMOR RECURRENCE; VAGINA TUMOR;

ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; COMBINED MODALITY THERAPY; ENDOMETRIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PELVIC NEOPLASMS; POSTOPERATIVE PERIOD; PROGNOSIS; PROSPECTIVE STUDIES; QUALITY OF LIFE; RISK FACTORS; SURVIVAL RATE; VAGINAL NEOPLASMS;

EID: 84873265157     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e3182643ba0     Document Type: Conference Paper

References (32)

1. Aalders J, Abeler V, Kolstad P, et al. Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathological study of 540 patients. Obstet Gynecol. 1980;56:419-427.
2. Creutzberg CL, van Putten WL, Koper PC, et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet. 2000;355:1404-1411.
3. Keys HM, Roberts JA, Brunetto VL, et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecol Oncol Group study. Gynecol Oncol. 2004;92:744-751.
4. The ASTEC/EN.5 Writing Committee on behalf of the ASTEC/EN.5 Study Group. Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and metaanalysis. Lancet. 2009;373:137-146.
5. Nout RA, Smit VT, Putter H, et al. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial. Lancet. 2010;375:816-823.
6. Sorbe B, Horvath G, Andersson H, et al. External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma-A prospective randomized study. Int J Radiat Oncol Biol Phys. 2012;82:1249-1255.
7. Högberg T, Signorelli M, de Oliveira CF, et al. Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer-results from two randomized studies. Eur J Cancer. 2010;36:371-378.
8. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365-376.
9. Greimel E, Bottomley A, Cull A, et al. An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-OV28) in assessing the quality of life of patients with ovarian cancer. Eur J Cancer. 2003;39:1402-1408.
10. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31:1341-1346.
11. Fayers P, Aaronson NK, Bjordal K. On behalf of the EORTC Quality of Life Study Group. The EORTC QLQ-C30 Scoring Manual. 3rd ed. Brussels, Belgium: EORTC; 2001.
12. Osoba D, Rodrigues G, Myles J, et al. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol. 1998;16:139-144.
13. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrica. 1951;16:297-334.
14. Poulsen HK, Jacobsen M, Bertelsen K, et al. Adjuvant radiation therapy is not necessary in the management of endometrial carcinoma stage I, low-risk cases. Int J Gynecol Cancer. 1996;6:38-43.
15. Obermaier A, Cheuk R, Pak SC, et al. Disease-free survival after vaginal vault brachytherapy versus observation for patients with node-negative intermediate-risk endometrial adenocarcinoma. Gynecol Oncol. 2008;110:280-285.
16. Sorbe B, Nordström B, Mäenpäa J, et al. Intravaginal brachytherapy in FIGO stage I low-risk endometrial cancer: a controlled randomized study. Int J Gynecol Cancer. 2009;19:873-878.
17. Schink JC, Rademaker AW, Miller DS, et al. Tumor size in endometrial cancer. Cancer. 1991;67:2791-2794.
18. Cohn DE, Horowitz NS, Mutch DG, et al. Should the presence of lymphovascular space involvement be use to assign patients to adjuvant therapy following hysterectomy for unstaged endometrial cancer? Gynecol Oncol. 2002;87:243-246.
19. Derogar M, van der Schaaf M, Lagergren P. Reference values for the EORTC QLQ-C30 quality of life questionnaire in a random sample of the Swedish population. Acta Oncol. 2012; 51:10-16.
20. Nout RA, Putter H, Jurgenliemk-Schulz IM, et al. Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trial. J Clin Oncol. 2009;27:3547-3556.
21. Nout RA, van de Poll-Franse LV, Lybeert MLM, et al. Long-term outcome and quality of life of patients with endometrial carcinoma treated with or without pelvic radiotherapy in the Post Operative Radiation Therapy in Endometrial Carcinoma 1 (PORTEC-1) trial. J Clin Oncol. 2011;29:1692-1700.
22. Quick AM, Seamon LG, Abdel-Rasoul M, et al. Sexual function after intracavitary vaginal brachytherapy for early-stage endometrial carcinoma. Int J Gynecol Cancer. 2012;22:703-708.
23. Greimel E, Nordin A, Lanceley A, et al. Psychometric validation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Endometrial Cancer Module (EORTC QLQ-EN24). Eur J Cancer. 2011;47:183-190.
24. Creutzberg CL, van Putten WL, Koper PC, et al. The morbidity of treatment for patients with Stage I endometrial cancer: Results from a randomized trial. Int J Radiat Oncol Biol Phys. 2001;51:1246-1255.
25. Jhingran A, Winter K, Portelance L, et al. A phase II study of intensity modulated radiation therapy to the pelvis for postoperative patients with endometrial carcinoma: radiation therapy oncology group trial 0418. [published online ahead of print, April 27, 2012]. Int J Radiat Oncol Biol Phys.
26. Yang R, Xu S, Jiang J, et al. Dosimetric comparison of postoperative whole pelvic radiotherapy for endometrial cancer using three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, and helical tomotherapy. Acta Oncol. 2010;49:230-236.
27. Georg P, Georg D, Hillbrand M, et al. Factors influencing bowel sparing in intensity modulated whole pelvic radiotherapy for gynaecological malignancies. Radiother Oncol. 2006;80:19-26.
28. Creutzberg CL, van Putten WL, Warlam-Rodenhuis CC, et al. Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the Postoperative Radiation Therapy in Endometrial Carcinoma Trial. J Clin Oncol. 2004;22:1234-1241.
29. Mundt AJ, McBride R, Rotmensch J, et al. Significant pelvic recurrence in high-risk pathologic stage I-IV endometrial carcinoma patients after adjuvant chemotherapy alone: implications for adjuvant radiation therapy. Int J Radiat Oncol Biol Phys. 2001;50:1145-1153.
30. Benedetti PP, Basile S, Maneschi F, et al. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst. 2008;100:1707-1716.
31. The ASTEC/EN.5 Writing Committee on behalf of the ASTEC Study Group. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomized study. Lancet. 2009;373:125-136.
32. Mariani A, Dowdy SC, ClibyWA, et al. Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecol Oncol. 2008;109:11-18.